- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hypertrophic Scars in Japan
Total 28 results
-
Bristol-Myers SquibbRecruitingHypertrophic CardiomyopathyJapan
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, Hypertrophic ObstructiveJapan
-
Nagoya UniversityUnknownHypertensive Left Ventricular HypertrophyJapan
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, HypertrophicSpain, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Hungary, Israel, Japan, Netherlands, Norway, Poland, Portugal, United Kingdom, United States, Australia, China, Czechia, India, Italy, Korea, Republic of
-
Hiroaki Shimokawa, MD, PhDUnknownHeart Failure | Coronary Disease | Heart Valve Diseases | Cardiomyopathies | Left Ventricular HypertrophyJapan
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2Japan
-
Astellas Pharma IncCompletedOveractive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic HypertrophyJapan
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
Astellas Pharma IncAstellas Pharma Singapore Pte. Ltd.Completed
-
AstraZenecaTerminatedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
Kringle Pharma, Inc.Recruiting
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2Japan
-
PfizerCompletedSARS-CoV-2 InfectionJapan
-
AstraZenecaCompletedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
MedicagoMitsubishi Tanabe Pharma CorporationTerminated
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
Ono Pharmaceutical Co. LtdCompletedSARS-CoV-2 Infection (COVID-19)Japan
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedCOVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
-
AstraZenecaRecruiting
-
ShionogiRecruitingSARS-CoV-2 InfectionJapan, United States
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey